· By Anne Whitaker

Innovation and Alzheimer’s Research

Analysts estimate that a treatment for Alzheimer’s disease (AD) could generate sales of $20 billion or more[i]. Unfortunately with the majority of AD clinical trials ending in failure, the prospect of success seems risky and costly, scaring companies away. Could collaborations be the answer? 
In April of this year an Alzheimer’s challenge was launched by […]

VIEW FULL POST
 · By Debboe Fenemore

Sanofi Stories: Catalyst for Change

For this installment of Sanofi Stories, I had the privilege of sitting down with Mike Labat, a Change Agent for the Local Solutions team and Market Access. Read our conversation below to see why Mike is truly a “catalyst of awesomeness.”
SB: Thanks so much for meeting with me today. To start, can you please tell […]

VIEW FULL POST
 · By Debboe Fenemore

#HCSM Perspectives: An Interview with the Man Behind @pharmaphorum

I am thrilled to take this opportunity to share a fascinating conversation that I recently had with Paul Tunnah, CEO & Founder of pharmaphorum media. Paul shared his thoughts on social media in the pharmaceutical industry, talked about his company’s conception, and gave some great advice to #HCSM stakeholders. Read on to see what he […]

VIEW FULL POST